Ann: Preliminary Final Report - 30 June 2012 , page-3

  1. 13,321 Posts.
    lightbulb Created with Sketch. 1237
    Smith Barney are confident Moxduo should get approval mid year.

    The FDA have requsted study 22.

    Price target $2.20.

    Regards,
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.